← Open Payments lookup

MEGAN SOLIS: Open Payments

NPI 1649729419 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,225 in 72 payments from 13 companies in 2025. Trend: 2023 $1,024 · 2024 $1,318 · 2025 $1,225

Food & beverage: $1,225
CompanyPaymentsAmount
ABBVIE INC.26$384
Aimmune Therapeutics, Inc.9$157
VIVUS LLC7$145
Takeda Pharmaceuticals U.S.A., Inc.6$117
QOL Medical, LLC3$75
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$73
Janssen Biotech, Inc.3$71
Lilly USA, LLC3$62
Phathom Pharmaceuticals, Inc.6$52
EVOKE PHARMA, INC.2$40

Products named: ZENPEP, RINVOQ, CREON, LINZESS, QSYMIA, Sucraid, XIFAXAN, TREMFYA.

Industry payments across TX — which companies pay providers there.